A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2006
10/31/2006	CA2136751C Salts of peptides with carboxy-terminated polyesters
10/27/2006	CA2505470A1 Drug delivery device
10/26/2006	WO2006113649A1 Pharmaceutical composition
10/26/2006	WO2006113631A2 Bioenhanced compositions
10/26/2006	WO2006113568A2 Controlled delivery dosage form of tramadol and gabapentin
10/26/2006	WO2006113310A2 Nanoparticulate and controlled release compositions comprising prostaglandin derivatives
10/26/2006	WO2006113309A1 Lacidipine particles
10/26/2006	WO2006113242A2 Method of increasing testosterone and related steroid concentrations in women
10/26/2006	WO2006112938A1 Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
10/26/2006	WO2006112889A1 Dosage forms of risedronate
10/26/2006	WO2006112869A2 Modulation of cytokine signaling regulators and applications for immunotherapy
10/26/2006	WO2006112744A2 Drug composition with analgesic, anti-inflammatory and decongestive activity
10/26/2006	WO2006112649A1 Pharmaceutical composition containing sibutramine free base and manufacturing method thereof
10/26/2006	WO2006112596A1 Controlled-release formulation containing tamsulosin hydrochloride
10/26/2006	WO2006112541A1 Method for the design of self-emulsifying drug formulations
10/26/2006	WO2006112533A1 Water-containing gel form and production method thereof
10/26/2006	WO2006112276A1 Propofol-containing fat emulsion
10/26/2006	WO2006112254A1 External preparation, method of applying external preparation, iontophoresis device and transdermal patch
10/26/2006	WO2006112235A1 Process for producing microcapsule, microcapsule production apparatus and microcapsule sheet
10/26/2006	WO2006112038A1 Dispersion ointment for treatment of hemorrhoids excellent in feeling after application and stability at high temperatures
10/26/2006	WO2006111853A2 Stable solid dosage forms of acid labile drug
10/26/2006	WO2006111490A1 Pharmaceutical composition comprising gas-filled microcapsules for ultrasound mediated delivery
10/26/2006	WO2006111429A1 A system for transmembrane administration of a permeant
10/26/2006	WO2006111258A1 Anti-irritating cough mixture containing extracts from island moss and mallow
10/26/2006	WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006	WO2006092727A3 Process for the production of calcium compositions in a continuous fluid bed
10/26/2006	WO2006080903A3 High concentration self-microemulsifying coenzyme q10 preparations for nutritional use
10/26/2006	WO2006079921A3 Drying of drug-containing particles
10/26/2006	WO2006069985A3 Production of lipid-based nanoparticles using a dual asymmetrical centrifuge
10/26/2006	WO2006066941A3 Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
10/26/2006	WO2006060542A3 Formulations of substituted benzoxazoles
10/26/2006	WO2006060384A3 Formulations of substituted benzoxazoles
10/26/2006	WO2006054307B1 Controlled absorption of statins in the intestine
10/26/2006	WO2006053175A3 A stabilized polymeric delivery system
10/26/2006	WO2006046114A3 Osmotic dosage forms providing ascending drug release, and processes for their preparation
10/26/2006	WO2006044548A3 Clopidogrel compositions
10/26/2006	WO2006032464A3 Method of treatment of acute exudative skin lesions and composition useful therefor
10/26/2006	WO2006032018A3 Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor
10/26/2006	WO2006001035A3 Synergistic liposomal tamoxifen composition for topical application and method of preparing thereof.
10/26/2006	WO2005048976A3 Foams comprising a sclerosing and a viscosity enhancing agent, methods for production thereof
10/26/2006	WO2004078147A3 Oxytocin controlled release formulations and methods of using same
10/26/2006	US20060241568 Arthroscopic chondrocyte implantation method and device
10/26/2006	US20060241551 Pivoting joint infusion system with seal
10/26/2006	US20060241466 Hollow microspheres with controlled fragility for medical use
10/26/2006	US20060241305 Amorphous form of losartan potassium
10/26/2006	US20060241182 Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives
10/26/2006	US20060241170 Methods and formulations of taxanes
10/26/2006	US20060241066 Decoy composition for treating and preventing inflammatory disease
10/26/2006	US20060241045 Method for producing preparation containing bioactive substance
10/26/2006	US20060241001 Composition for treating contact lenses
10/26/2006	US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
10/26/2006	US20060240128 Combined immediate release and extended release analgesic composition
10/26/2006	US20060240123 Pharmaceutical composition
10/26/2006	US20060240114 Drug for treating hemophilia and method of treating hemophilia using the same
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	US20060240112 removal of DNA associated with riboflavin (vitamin B2) crystals; fermentation; precipitation; crystallization
10/26/2006	US20060240111 Semi-solid mucoadhesive formulations
10/26/2006	US20060240110 electrospun into fibers permitting immobilization and long-term delivery of biodrugs; compatibilizing polyoxyethylene glycol and low molecular weight heparin or heparin-binding peptide covalently attached
10/26/2006	US20060240109 low bulk density; composites including sheared cellulosic or lignocellulosic fibers; biodegradable, impact strength, lightweight, low cost; use in variety of applications such as various construction materials, textiles, drug delivery
10/26/2006	US20060240108 Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
10/26/2006	US20060240107 Controlled-release compositions
10/26/2006	US20060240106 Enteric coated composition comprising prostaglandin analogs as chloride channel opener
10/26/2006	US20060240105 Multiparticulate modified release composition
10/26/2006	US20060240104 Controlled or sustained-release formulation
10/26/2006	US20060240103 Effervescent compositions comprising bisphosphonates and methods related thereto
10/26/2006	US20060240102 Binders for tablets with high strength based on finely divided vinyllactam polymers, the production and use thereof
10/26/2006	US20060240101 Orally disintegrating pharmaceutical tablet formulations of olanzapine
10/26/2006	US20060240100 Dosage form containing pantoprazole as active ingredient
10/26/2006	US20060240099 High-amylose starch
10/26/2006	US20060240098 Formulations for hyperforin-enriched hypericum fractions
10/26/2006	US20060240097 (4-[((6E)-8-Methylnon-6-enoylamino)methyl]-2-methyoxyphenyl formate), for example; treatment of pain associated with postherpetic neuralgia, diabetic neuropathy, HIV-associated neuropathy, complex regional pain syndrome, cancer, nerve injury, cancer chemotherapy
10/26/2006	US20060240096 Devices and methods for treating the gastrointestinal system
10/26/2006	US20060240095 Pharmaceutical composition comprising a combination of metformin and a statin
10/26/2006	US20060240094 Masticatable capsule and process for producing the same
10/26/2006	US20060240093 silencing gene expression by delivering nucleic acid-lipid particles comprising a siRNA molecule to a cell; hepatitis
10/26/2006	US20060240092 Polymeric micelles for drug delivery
10/26/2006	US20060240091 a targeting peptide from the C-terminal of endothelin and/or a novel fusogenic peptide from hemagglutinin; for delivering liposomes encapsulating cholinesterase genes particularly the human serum butyryl cholinesterase (Hu BChE) gene as a treatment against nerve agents
10/26/2006	US20060240090 Combination compositions of camptothecins and fluoropyrimidines
10/26/2006	US20060240089 Use of pvp-iodine liposomes for treatment of herpes
10/26/2006	US20060240088 Caged ligands and uses thereof
10/26/2006	US20060240087 Composition and methods for drug delivery
10/26/2006	US20060240086 Adhesive patch
10/26/2006	US20060240085 Treatment of dependence withdrawal
10/26/2006	US20060240082 Method for manufacture of improved cleaning and washing products
10/26/2006	US20060240081 Disposable; multilayer netting; for body cleansing
10/26/2006	US20060240080 Alginate sponge and preparation method thereof
10/26/2006	US20060240078 Feed supplement delivery system
10/26/2006	US20060240071 Non-hormonal vaginal contraceptive
10/26/2006	US20060240065 Compositions for medical devices containing agent combinations in controlled volumes
10/26/2006	US20060240052 Ketoprofen compositions and methods of making them
10/26/2006	US20060240051 Eutectic blends containing a water soluble vitamin derivative
10/26/2006	US20060240050 Stable clozapine suspension formulation
10/26/2006	US20060240049 Anti-protozoal compositions comprising diclazuril
10/26/2006	US20060240009 Liposome composition for improved intracellular delivery of a therapeutic agent
10/26/2006	US20060239986 Method for the formation of hydrogel multilayers through surface initiated photopolymerization
10/26/2006	US20060239975 Methods for treating cancers and restenosis with p21
10/26/2006	US20060239962 Rapid one-step generation of antigen loaded dendritic cell vaccine from precursors
10/26/2006	US20060239957 Using extract of olive leaves
10/26/2006	US20060239947 Biliquid foams stable dispersions thereof and a corresponding process of manufacturing
10/26/2006	US20060239937 Stable foam cream

1 ... 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 ... 2991